ATRA
Atara Biotherapeutics Inc
Price:  
9.30 
USD
Volume:  
178,795.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara WACC - Weighted Average Cost of Capital

The WACC of Atara Biotherapeutics Inc (ATRA) is 17.6%.

The Cost of Equity of Atara Biotherapeutics Inc (ATRA) is 10.00%.
The Cost of Debt of Atara Biotherapeutics Inc (ATRA) is 28.45%.

Range Selected
Cost of equity 7.70% - 12.30% 10.00%
Tax rate -% - -% -%
Cost of debt 7.00% - 49.90% 28.45%
WACC 7.4% - 27.7% 17.6%
WACC

Atara WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.84 1.32
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 12.30%
Tax rate -% -%
Debt/Equity ratio 0.7 0.7
Cost of debt 7.00% 49.90%
After-tax WACC 7.4% 27.7%
Selected WACC 17.6%